Book I: Health establishments

External radiotherapy is a cancer treatment method that uses ionising radiation to destroy cancer cells using rays produced by a linear particle accelerator, while sparing peripheral healthy tissue as much as possible with the aid of an imaging device. Brachytherapy is a radiotherapy technique in which sealed radioactive sources are implanted inside the body of a cancer patient, either directly into the tumour or in contact with it.

The “External radiotherapy, brachytherapy” modality comprises the following entries: 1° Entry A providing external radiotherapy treatment for adults; 2° Entry B providing brachytherapy treatment for adults; 3° Option C providing the same treatments for children and adolescents under the age of eighteen, in addition to external radiotherapy or brachytherapy treatments for adults.

Systemic drug treatments for cancer include chemotherapy, targeted therapies, immunotherapy and advanced therapy drugs, whatever the route of administration.

The “Systemic drug treatments for cancer” modality comprises the following entries: 1° Entry A providing systemic drug treatments for cancer in adults, excluding intensive chemotherapy mentioned in entry B; 2° Entry B providing, in addition to systemic drug treatments for cancer in adults, intensive chemotherapy leading to foreseeable aplasia of more than eight days and the management of this foreseeable aplasia; 3° Mention C providing systemic medicinal treatments for cancer…

Establishments are not subject to authorisation for cancer treatment when they provide: 1° Surgery to diagnose cancer; 2° For patients with an established cancer diagnosis, surgery to treat or alleviate a complication linked to the consequences of cancer or its treatment, without attempting to remove the tumour; 3° An emergency operation for another indication, leading to the discovery of a malignant tumour. The operation is then carried out without attempting…

I.- Authorisation holders for medicine, surgery, interventional radiology, medical care and rehabilitation or home hospitalisation may be associated with an authorisation holder for cancer treatment using systemic medicinal treatments. II.-Within the framework of a formalised organisation with this authorisation holder, and without being subject to the cancer treatment authorisation, these establishments may: 1° Apply systemic cancer drug treatments decided upon and first prescribed by the authorisation holder for systemic cancer…

The following are not subject to authorisation for cancer treatment: 1° Holders of an authorisation to carry out nuclear medicine or interventional radiology care activities when they carry out diagnostic or therapeutic cancer procedures related to this authorisation; 2° Health establishments or persons who participate in the local care of cancer patients in association with an authorisation holder, by providing these patients with medical and rehabilitation care or palliative care.